Sumatriptan succinate and Methotrexate sodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sumatriptan succinate (sumatriptan succinate) and Methotrexate sodium (methotrexate sodium). Common drug interactions include drug ineffective among females and nonspecific reaction among males.

The phase IV clinical study analyzes what interactions people have when they take Sumatriptan succinate and Methotrexate sodium. It is created by eHealthMe based on reports of 91 people who take the same drugs from the FDA, and is updated regularly.

What is Sumatriptan succinate?

Sumatriptan succinate has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 9,731 Sumatriptan succinate users. Check the latest studies of Sumatriptan succinate.

What is Methotrexate sodium?

Methotrexate sodium has active ingredients of methotrexate sodium. It is often used in rheumatoid arthritis. eHealthMe is studying from 97,679 Methotrexate sodium users. Check the latest studies of Methotrexate sodium.



On Jul, 09, 2026

91 people who take Sumatriptan succinate and Methotrexate sodium together, and have interactions are studied.

Sumatriptan succinate and Methotrexate sodium drug interactions.

What are the common drug interactions of Sumatriptan Succinate and Methotrexate Sodium, by gender? *:

female:

  1. Drug ineffective
  2. Drug intolerance (drug sensitivity)
  3. Hypertension (high blood pressure)
  4. Arthralgia (joint pain)
  5. Asthma
  6. Chronic kidney disease
  7. Depression
  8. Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain)
  9. Joint swelling
  10. Psoriasis (immune-mediated disease that affects the skin)

male:

  1. Nonspecific reaction (unspecified reaction)
  2. Blood glucose increased
  3. Kidney infection
  4. Pain
  5. Fatigue (feeling of tiredness)
  6. Renal failure (kidney dysfunction)
  7. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  8. Cardiac disorder
  9. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  10. Fluid retention (an abnormal accumulation of fluid in the blood)

What are the common drug interactions of Sumatriptan Succinate and Methotrexate Sodium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Drug screen false positive
  2. Vomiting

30-39:

n/a

40-49:

  1. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Decreased interest
  4. Erythema (redness of the skin)
  5. Immunodeficiency
  6. Injection site burning
  7. Injection site erythema (redness at injection site)
  8. Mobility decreased (ability to move is reduced)
  9. Nausea (feeling of having an urge to vomit)
  10. Pain

50-59:

  1. Asthma
  2. Chronic kidney disease
  3. Depression
  4. Drug ineffective
  5. Drug intolerance (drug sensitivity)
  6. Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain)
  7. Hypertension (high blood pressure)
  8. Psoriasis (immune-mediated disease that affects the skin)
  9. Drug specific antibody present
  10. Abdominal distension

60+:

  1. Fatigue (feeling of tiredness)
  2. Arthralgia (joint pain)
  3. Hypertension (high blood pressure)
  4. Therapeutic response decreased (less preventive response)
  5. Nonspecific reaction (unspecified reaction)
  6. Blood glucose increased
  7. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Cardiac disorder
  10. Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

  1. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 23 people, 25.27%
  2. Parkinson's Disease: 7 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Sumatriptan succinate and Methotrexate sodium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sumatriptan succinate and Methotrexate sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sumatriptan succinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Methotrexate sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sumatriptan succinate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methotrexate sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on sumatriptan succinate and methotrexate sodium (the active ingredients of Sumatriptan succinate and Methotrexate sodium, respectively), and Sumatriptan succinate and Methotrexate sodium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: